Abcellute
London
About Abcellute
Abcellute is to achieve global adoption of its SureCell™ cell transport technology by providing the research community with enhanced, fresh-cell systems. These will maximise the utilisation of this often scarce resource and provide products that are much more convenient to use than current fresh-cell systems. This will deliver benefits to biomedical researchers in key areas such as pre-clinical drug evaluation and regenerative medicine.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $807.3K
- Last round: Undisclosed (Sep 2007)
- Website: abcellute.com
- Phone: 44 2920 765080
Industries & Categories
Biotechnology
Canonical: https://fsome.com/organization/abcellute-2337156 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.